Do you still think Galmed Pharmaceuticals Ltd. (NASDAQ:GLMD) is worth a look?

In yesterday’s Wall Street session, Galmed Pharmaceuticals Ltd. (NASDAQ:GLMD) shares traded at $2.08, down -14.40% from the previous session. As of this writing, 1 analysts cover Galmed Pharmaceuticals Ltd. (NASDAQ:GLMD). The consensus rating among analysts is ‘Hold’. As we calculate the median target price by taking the range between a high of $15.00 and a […]